| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08.05. | BIO-RAD LABORATORIES, INC. - S-8, Securities to be offered to employees in employee benefit plans | 2 | SEC Filings | ||
| 08.05. | BIO-RAD LABORATORIES, INC. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 08.05. | Leichter Wertverlust bei der Bio-Rad Laboratories-Aktie (250,0652 €) | 241 | ARIVA.de | Im Minus liegt derzeit die Bio-Rad Laboratories-Aktie . Das Wertpapier notiert gegenwärtig bei 268,65 US-Dollar. Die Bio-Rad Laboratories-Aktie verzeichnet zur Stunde einen Abschlag von 4,02 Prozent.... ► Artikel lesen | |
| 08.05. | Bio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Down | 4 | Zacks | ||
| 08.05. | Bio-Rad Laboratories, Inc. (BIO) Q1 2024 Earnings Call Transcript | 4 | Insider Monkey | ||
| 08.05. | Earnings call: Bio-Rad sees decline in Q1 sales but maintains full-year outlook | 7 | Investing.com | ||
| 07.05. | BIO-RAD LABORATORIES, INC. - 8-K, Current Report | 3 | SEC Filings | ||
| 07.05. | Bio-Rad Reports First-Quarter 2024 Financial Results | 72 | Business Wire | HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results... ► Artikel lesen | |
| 26.04. | BIO-RAD LABORATORIES, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 16.04. | Bio-Rad (BIO) Hurt by Softness in BioPharma and Competition | 9 | Zacks | ||
| 16.04. | Bio-Rad and Oncocyte partner to develop and commercialise transplant monitoring products | 7 | PharmaTimes | ||
| 15.04. | Earnings call: OncoCyte outlines growth strategy and partnership with Bio-Rad | 5 | Investing.com | ||
| 12.04. | Oncocyte stock rallies 90% post-market on Bio-Rad partnership | 35 | Seeking Alpha | ||
| 12.04. | OncoCyte jumps on partnership with Bio-Rad | 32 | Reuters | ||
| 11.04. | OncoCyte Corporation: Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay | 235 | GlobeNewswire (Europe) | - Bio-Rad expects to make equity investment in support of deal - Agreement provides for global exclusivity in transplant monitoring commercialization - Bio-Rad granted subsequent investment option... ► Artikel lesen | |
| 10.04. | Bio-Rad's chief operating officer Andrew Last to retire | 9 | Seeking Alpha | ||
| 10.04. | BIO-RAD LABORATORIES, INC. - 8-K, Current Report | 7 | SEC Filings | ||
| 10.04. | Bio-Rad and Alleghany Health Network partner for patients with solid tumour cancer | 8 | PharmaTimes | ||
| 02.04. | Kursverluste für den Anteilsschein von Bio-Rad Laboratories (305,7197 €) | 4.532 | ARIVA.de | Im Minus liegt gegenwärtig der Anteilsschein von Bio-Rad Laboratories . Der jüngste Kurs betrug 329,04 US-Dollar. Die Aktie von Bio-Rad Laboratories verzeichnet zur Stunde ein Minus von 2,93 Prozent.... ► Artikel lesen | |
| 20.03. | Bio-Rad names Roop Lakkaraju as CFO | 4 | MassDevice |
Seite:
1 2 3 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| GAMESTOP | 6.938 |
| EVOTEC | 5.600 |
| TUI | 5.173 |
| PLUG POWER | 3.663 |
| AMC ENTERTAINMENT | 3.316 |
| NEL | 3.304 |
| BAYER | 2.573 |
| SIEMENS ENERGY | 2.409 |
| RHEINMETALL | 2.238 |
| NVIDIA | 2.213 |
| COMMERZBANK | 2.018 |
| AIXTRON SE | 1.786 |
| DEUTSCHE BANK | 1.739 |
| ALLIANZ | 1.676 |
| RWE | 1.615 |
| MERCEDES-BENZ | 1.559 |
| THYSSENKRUPP | 1.547 |
| THYSSENKRUPP NUCERA | 1.460 |
| BYD | 1.458 |
| SUPER MICRO COMPUTER | 1.399 |
| RENK GROUP | 1.358 |
| VOLKSWAGEN | 1.296 |
| NORDEX | 1.179 |
| DEUTSCHE TELEKOM | 1.117 |
| SIEMENS | 1.102 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
